Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Yep, the opening nonsequential trade volume does not show on my volume chart.
I added a few shares on a whim. It just seemed like a good time.
The update with the share buyback schedule suggests RNVA will beat that estimate handily.
Big opening coming Monday?
You don't understand common share equivilency. Comments like that make you look stupid.
Uber is uber out of date.
https://www.sec.gov/ix?doc=/Archives/edgar/data/931059/000149315224011342/form8-k.htm
Excess money in large caps and major exchanges due to shift microcaps and OTC value. Health care a good target for some sector shifting too. RNVA is a strong value. Doesn't belong in 000s, never did.
Not unsusal at all. I have seen the SEC review process kick in a number of times for OTCs over last 20+ years, often delaying the date an a 10-K filing is posted. Companies earnest about compliance come out fine.
https://www.sec.gov/divisions/corpfin/cffilingreview
All is well. Strap in. The fun part is about to be unleashed.
Keep your eye on the ball. Insider manipulation was the driver of almost all subpenny stock runs in the past. That ended September '21. Now, the OTC market has to consider the fundamentals, not just technical trading. That is a good thing, in fact the best thing, for RNVA after being oversold and artificially diluted by disproportionate short selling. The PE under 2 speaks for itself. The PE will be closer to 1 in this annual report. If you are an investor in RNVA, you are aruing against yourself. RNVA is poised to break out of the 000s and become the only game in town for technical traders.
You may have also noticed the current SEC compliant OTCBBs are down to mostly companies with low overhead and, therefore, really simple quarterly reports. I'm sure the SEC is aware of the compliance burdens of a company like RNVA, recovering and gradually shedding past baggage. Just a review. I really think the annual report will set RNVA loose.
Yes they do. Read the link. The difference is that being a pink sheet means with the review, flagged for whatever reason or however frequently, the listing status is on the line by definition. Granted, filing late didn't help, but RNVA's filings are better than most on the OTC. Should clear review without much falderal.
Every company gets a filing(s) flagged at least once every three years:
https://www.sec.gov/divisions/corpfin/cffilingreview
Happens all the time. Hell, the 10-K was probably too good for the SEC regululator to believe it is true. LOL
Did you just say you have been buying while all the time you have been talking it down?
A lot of crap being cleaned up in the ongoing financial restructuring, but that makes for a damned complicated annual audit. Don't know, of course, but I would bet the 10-K is on the desk of some SEC regulator asking the CEO or the auditor to explain some obscure line in the 10-K or the audit report.
How do you know it hasn't been filed?
Last year the NT 10-K was filed on March 31, the due date, but the 10-K didn't post until April 17, a Wednesday. The original due date this year was April 1, so it should clear anytime now. The SEC has been scrubing annual reports more thoroughly than in days gone by. No sweat.
Dude, get a f-ing perspective. RNVA does not have the resources of a Fortune 500 company. SEC filings are disproportionately expensive and burdensome for microcaps. That's a common issue.
Have you ever done a $20 million financial audit?
I've seen 10-Ks filed on time but held up by something on the SEC checklist before posted. The financial restructuring (debt and preferred shares) is pretty complicated, but RNVA filings have been very detailed and very thorough. I can't imagine they let it slip.
Might have been wrong about that. It may be that the common shares repurchased upon issuance never show in the market volume because both buyer (the company) and seller are going through the transfer agent, meaning the shares exchange never go to a market maker. When the April 15 buyback is confirmed, we'll know no heavy insider selling is in the way of a breakout and the future .0001 buybacks won't affect the market volume or drag down the price, a good thing.
15 minutes in....something.
That information to date of filing might be included in the introductory text. If not, an update should follow.
That must be right given that the due date fell on a weekend.
They have until midnight to file. Will have been posted by the time you log on tomorrow.
Do common shares repurchased upon issuance necessarily show in the volume traded on the open market? I'm thinking, since that is done through the transfer agent by both the buyer (the company) and the seller and would never go to a market maker, maybe not. Otherwise, we should see a billion shares in nonsequential trades show up before opening tomorrow. Either way, all will be clearer with the 10-K and related update.
That's what targets based on a forward P/E of 25 would look like. Jamestown expansion assumed for long term target. Let's see where the 2023 current P/E lands, but it should be somewhere between 1 and 2. RNVA was artificially diluted. The debt/interest reductions and the corporate equity buybacks are proving that out. An RS wouldn't affect the P/E, but I don't expect an RS until the stock sustains a price in the pennies and an uplisting in the works.
Sometime between now and close on Monday, the ticker is going to blow your mind.
Hilary is irrelevant. But, capitalism does not and cannot exist without rules of exchange. When you take that as a premise, you can then drill into who makes the rules and why. How would you answer this question? Does the economy exist to serve people, or do people exist to serve the economy?
We haven't heard from GeekOfSkidRow and his band of merry men for awhile. Did they get new instructions or something?
Smart investors? Not many Hoss, not in OTCs, but there are always exceptions to the rule.
You can consider that a buy signal.
Under certain conditions, a company can use an NT10-K to roll the 10-K into an annual report due April 15. Not sure exactly how that works, but I have noticed that a number of times with OTCs. I would guess the rule helps small companies minimize the cost of compliance, but just guessing.
Muhammad Ali. Who was the fighter who kept calling him "Clay?" In that fight, Ali pounded him, each time saying to him, "Say my name." It might have been the only thime Ali fought mad.
All investor concerns adressed: corporate equity and debt restructured, OS leveled, no more dilution, ongoing debt and interest reductions, and we know that agreement wouldn't have been reached without showing the earnings to meet the buyback schedule, nor would an institutional warrant holder provide the backstop without being satisfied with the earnings growth.
Pay attention. Those are shares being registered for buyback at .0001.
You won't see any more reloads of the ask by insiders.
Okay, it's less complicated than I thought. It's a corporate equity buyback plan locked in at .0001 per common share with one or more principal investor willing to average in at that price if the company needs the capital. This is smart because it lets the stock price correct without increasing the cost of the buyback. This is good stuff for shareholders. Here is the filing of the amended(updated) prospectus/insider trading plan: https://archive.fast-edgar.com/20240326/AJ2OS22CZC2RG2Q2222D2WY29UKFZZ22G262/
Jamestown is a bit more complicated because of the institutional and community partnerships involved. That's a good thing though as I see it. All hinges on the CAH certification, which seems to be what Rennova has the capacity to bring to the table. Even nonprofits don't like losing money. Will be interesting to see how that unfolds.
This is what I surmise, not what I know for sure, but I think the company has been buying back common shares converted from prefrerred shares since early November (when the OS quit growing), and the company will continue to buy back unless and until capital is needed to reestablish (CAH reimbursable) services at Jamestown. Then, the institutional warrant holders start buying them, which won't be for dillution but expansion. That appears to be the strategy, and the numbers work (estimating based on the revenue guidance).